Apurva Thekdi, MD
Otolaryngology · Houston, TXNPI 1053356238
Payments from drug & device makers
Across 44 payments — averaging $336.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$10K
- Intersect ENT, Inc.$3K
- Lumenis, Inc$396
- Kerecis Limited$395
- Acera Surgical, Inc.$320
- Fisher & Paykel Healthcare Inc$240
- plus $759 from 11 others
What the payments were for
- Consulting fees$10,00068%
- Speaking & faculty fees$3963%
- Travel & lodging$1,96213%
- Food & beverage$2,43916%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 3 | $10,162 |
| Intersect ENT, Inc. | 6 | $2,526 |
| Lumenis, Inc | 1 | $396 |
| Kerecis Limited | 2 | $395 |
| Acera Surgical, Inc. | 5 | $320 |
| Fisher & Paykel Healthcare Inc | 2 | $240 |
| Regeneron Healthcare Solutions, Inc. | 6 | $233 |
| Inspire Medical Systems, Inc. | 6 | $112 |
| KARL Storz Endoscopy-america | 1 | $90 |
| Medtronic | 2 | $78 |
| Acclarent, Inc | 2 | $72 |
| Merck | 2 | $43 |
| Optinose US, Inc. | 2 | $41 |
| Kls-martin L.p. | 1 | $29 |
| Ambu Inc. | 1 | $22 |
| Cochlear Americas | 1 | $21 |
| Sanofi | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lumenis Pulse 120H$10,396
- SINUVA$2,526
- FISHER & PAYKEL HEALTHCARE$1,202
- Kerecis SurgiClose$947
- Kerecis Omega3 Marigen$632
- Restrata Wound Matrix$270
- Kerecis GraftGuide$237
- GENERAL - THERAPIES$162
- Kerecis Omega3 SurgiClose$158
- LIBTAYO$124
How this compares
$14,798 in reported general payments places this provider in the 85th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 27 | $1,387 |
| Pantoprazole Sodium | 49 | $614 |
| Gabapentin | 47 | $443 |
| Azelastine Hcl | 12 | $411 |
| Fluticasone Propionate | 19 | $289 |
| Amitriptyline Hcl | 21 | $119 |
| Cephalexin | 22 | $97 |
| Montelukast Sodium | 11 | $81 |
| Clonazepam | 16 | $80 |
| Mupirocin | 12 | $79 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $73 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 23 | $70 |
| Levofloxacin | 12 | $67 |
| Methylprednisolone | 15 | $63 |
| Tramadol Hcl | 15 | $29 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Houston
- Mark ZafereoHouston$7.8M
- Neil GrossHouston$1.5M
- Stephen LaiHouston$968K
- Amber LuongHouston$793K
- Masayoshi TakashimaHouston$644K
- Arjuna KuperanHouston$348K
- Ron KarniHouston$336K
- William YaoHouston$280K
- Martin CitardiHouston$264K
- Michael KaplanHouston$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.